Skip to main content
FDA Shortage Check

Is Teglutik (Riluzole Oral Suspension) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Teglutik: in shortage (FDA, Oct 24)

Oral suspensions
A generic oral suspension, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Requirements related to complying with good manufacturing practices”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.), Oct 15, 2026
DRUG
Teglutik
FDA LISTING
FORM
suspension
STATUS
Currently in Shortage
FIRST POSTED
Jan 26, 2024
LAST FDA UPDATE
Oct 15, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 4 presentations: 1 unavailable · 0 limited · 3 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Riluzole Oral Suspension. 4 presentations from 1 maker.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)4 presentations · 1 unavailable · 3 available or not stated

Contact (FDA's listing): 610-937-6172

  • 50 mg/10 mL

    Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)

    Estimated recovery: TBD

    NDC 70726-0303-1Reverified

    Unavailable

  • 5 mg/1 mL

    Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)

    NDC 70726-0304-1Reverified

    Available

  • 5 mg/1 mL

    Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)

    NDC 70726-0305-1Reverified

    Available

  • 5 mg/1 mL

    Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)

    NDC 70726-0306-1Reverified

    Available

What the manufacturers told FDA

  • EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) · ‘Estimated recovery: TBD’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Requirements related to complying with good manufacturing practices

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Teglutik in shortage?
Yes. As of Oct 24, 2026, FDA lists Riluzole Oral Suspension as currently in shortage: 4 presentations, 1 unavailable and 0 limited.
When will the Teglutik shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Teglutik?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.